Hubble Therapeutics

Hanover, NH · Founded 2000 · Privately Held (backing)

Developer of a gene therapy platform designed for a rare genetic eye disorder that typically presents with severe progressive visual impairment. Hubble Therapeutics is based in Hanover, NH and was founded in 2000. It has raised $20.3 million across 1 recorded round; the latest was a $9.8 million early-stage round in Oct 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$20.3M
Last round
Early Stage VC
Oct 2024

Who backs Hubble Therapeutics?

4 investors
InvestorType
WARF VenturesVenture capital
Wisconsin Alumni Research FoundationOther
Bluestem Capital Company—
Visionary Venture Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Hubble Therapeutics investors

4 investors are on record for Hubble Therapeutics, including WARF Ventures, Wisconsin Alumni Research Foundation, Bluestem Capital Company and Visionary Venture Fund. The early-stage round in Oct 2024 drew 17 investors.

Private Market View
More of Hubble Therapeutics with a free Private Market View account
  • ·Watch Hubble Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Hubble Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View